January 17, 2025
TOPLINE: Wearable devices are associated with a reduced risk for major adverse cardiovascular events and all-cause mortality in patients with ischemic heart disease. However, evidence of […]
January 15, 2025
Adding measures of anxiety and depression to the American Heart Association’s Predicting Risk of Cardiovascular Disease Events (PREVENT) model may have little additional effect on predicting […]
January 10, 2025
“Out of an abundance of caution,” Johnson & Johnson MedTech has temporarily paused the use of its Varipulse field ablation system in the United States, the […]
January 9, 2025
Texas-based medical device company Alleviant has received a breakthrough device status from the US Food and Drug Administration (FDA) for its new no-implant atrial shunt for […]
January 9, 2025
TOPLINE: An artificial intelligence–ECG risk estimation model designed to predict incident hypertension (AIRE-HTN) identifies cases and stratifies the risk for adverse outcomes in addition to traditional […]
January 8, 2025
TOPLINE: Patients presenting with advanced breast cancer at diagnosis are more likely to have prevalent cardiovascular disease, and this association is more specific to hormone receptor–positive […]
December 26, 2024
TOPLINE: Compared with later cardiac reoperations, early reoperations demonstrate increased technical complexity with longer operative times and higher requirements for blood transfusion yet show no significant […]
December 26, 2024
TOPLINE: Impairment in cardiac baroreflex sensitivity, which helps regulate blood pressure, is associated with an increased risk for dementia and mortality in older adults not taking […]
December 24, 2024
Middle-aged women who did many short bursts of vigorous-intensity exercise — amounting to as little as 3 min/d — had a 45% lower risk for major […]